Middle East and Africa Heparin Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • MEA
  • 350 Pages
  • No of Tables: 106
  • No of Figures: 33

Middle East and Africa Heparin Market By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH), Mode of Administration (Oral Administration, Parenteral Administration), Source (Bovine, Porcine), Ingredients(Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others), Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others), Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others), Type (Generics, Brands), Container (Bottles, Bags, Vials, Others), Packaging (Glass, Plastic), End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Store, Online Pharmacy, Others), Country (South Africa, rest of Middle East and Africa) – Industry Trends and Forecast to 2026

Heparin is medication is used to prevent and treat blood clots. It is used to treat blood clotting disorders. It is also used to prevent blood clots after surgery, during blood transfusions, dialysis, and blood samples. It helps in smooth blood flowing by releasing anti-clotting protein. It is known as an anticoagulant. It is also used in diagnose and treatment of disseminated intravascular coagulation, deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It cannot dissolve blood clots but only prevent the clots from becoming larger and causing more serious problems. Heparin is an animal-derived product, derived from mucosal tissues of slaughtered meat animals.

Heparin is used for Diagnosis of heart attacks and unstable angina, Inhibition of cancer, metabolic disorders and hepatitis, as an anti-inflammatory drug in injuries as Anti-Coagulants in blood sampling.

Middle East and Africa heparin market is projected to register a steady CAGR in the forecast period 2019 to 2026.

Segmentation: Middle East and Africa Heparin Market

Middle East and Africa Heparin market is segmented into fourteen notable segments which are product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, brands, Type, container, packaging, end user, distribution channel.

  • On the basis of product type, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH)
  • On the basis of mode of administration, the market is segmented into oral administration and parenteral administration
  • On the basis of source, the market is segmented into bovine and porcine
  • On the basis of ingredients, the market is segmented into sodium and calcium and others
  • On the basis of availability, the market is segmented into raw, and processed
  • On the basis of treatment, the market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others
  • On the basis of application, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others
  • On the basis of therapeutics, the market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others
  • On the basis of strength, the market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others
  • On the basis of type, the market is segmented into generics and brands
  • On the basis of container, the market is segmented into bottles, bags, vials and others
  • On the basis of packaging, the market is segmented into glass and plastic
  • On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy & drug store, online pharmacy and others

Competitive Analysis: Middle East and Africa Heparin Market

  • Some of the major players operating in this market are Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd , Mylan N.V., Aspen Holdings, Changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, OPOCRIN S.P.A, SARIA SE & Co. KG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Yino Pharma Limited, and among others.

Recent Developments:

  • In 2019 Aspen Holding (South Africa) has transferred manufactures of Fraxiparine and Mono-embolex vials to Port Elizabeth site. Transfer of Mono-embolex prefilled syringes to its Notre Dame de Bondeville site. The main purpose of this transfer is to enhance the production capacity.
  • In April 2018, Hikma Pharmaceuticals PLC (Jordan) announced that it has signed a licensing agreement with Laboratorios Farmaceúticos Rovi SA for their enoxaparin biosimilar.
  • In 2015 Aspen holding (South Africa) acquired rights of Mono-Embolex from Novartis AG (Switzerland) Mono-Embolexis an injectable anti-coagulant. It is low molecular weight the main focus of this product acquisition is to expand the therapeutic area portfolio.

Research Methodology: Middle East and Africa Heparin Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 2 MIDDLE EAST AND AFRICA UNFRACTIONATED HEPARIN IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 3 MIDDLE EAST AND AFRICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 4 MIDDLE EAST AND AFRICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2016-2026 (USD MILLION) 

TABLE 5 MIDDLE EAST AND AFRICA ULTRA LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 6 MIDDLE EAST AND AFRICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY TYPE, 2016-2026 (USD MILLION) 

TABLE 7 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION) 

TABLE 8 MIDDLE EAST AND AFRICA ORAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 9 MIDDLE EAST AND AFRICA PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION) 

TABLE 10 MIDDLE EAST AND AFRICA PARENTRAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 11 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION) 

TABLE 12 MIDDLE EAST AND AFRICA BOVINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 13 MIDDLE EAST AND AFRICA PORCINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 14 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY INGREDIENTS, 2016-2026 (USD MILLION) 

TABLE 15 MIDDLE EAST AND AFRICA SODIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 16 MIDDLE EAST AND AFRICA CALCIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 17 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 18 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION) 

TABLE 19 MIDDLE EAST AND AFRICA RAW IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 20 TABLE1 MIDDLE EAST AND AFRICA PROCESSED IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 21 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION) 

TABLE 22 MIDDLE EAST AND AFRICA DEEP VEIN THROMBOSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 23 MIDDLE EAST AND AFRICA PULMONARY EMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 24 MIDDLE EAST AND AFRICA ARTERIAL THROMBOEMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 26 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 

TABLE 27 MIDDLE EAST AND AFRICA PRE-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 28 MIDDLE EAST AND AFRICA POST-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 29 MIDDLE EAST AND AFRICA KIDNEY DIALYSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 30 MIDDLE EAST AND AFRICA DIAGNOSTIC TEST IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 31 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 32 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION) 

TABLE 33 MIDDLE EAST AND AFRICA CARDIOVASCULAR IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 34 MIDDLE EAST AND AFRICA RESPIRATORY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 35 MIDDLE EAST AND AFRICA ONCOLOGY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 36 MIDDLE EAST AND AFRICA NEPHROLOGY IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION) 

TABLE 37 MIDDLE EAST AND AFRICA CNS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 39 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION) 

TABLE 40 MIDDLE EAST AND AFRICA 10 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION) 

TABLE 41 MIDDLE EAST AND AFRICA 100 UNIT IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 42 MIDDLE EAST AND AFRICA 1000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 43 MIDDLE EAST AND AFRICA 5000 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION) 

TABLE 44 MIDDLE EAST AND AFRICA 10000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 45 MIDDLE EAST AND AFRICA 25000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 46 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 47 MIDDLE EAST AND AFRICA GENERICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 48 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY BRANDED, 2017-2026 (USD MILLION) 

TABLE 49 MIDDLE EAST AND AFRICA BRANDEDS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 50 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION) 

TABLE 51 MIDDLE EAST AND AFRICA BOTTLES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 52 MIDDLE EAST AND AFRICA BAGS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 53 MIDDLE EAST AND AFRICA VIALS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 55 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION) 

TABLE 56 MIDDLE EAST AND AFRICA GLASS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 57 MIDDLE EAST AND AFRICA PLASTIC IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 58 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION) 

TABLE 59 MIDDLE EAST AND AFRICA HOSPITALS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION) 

TABLE 60 MIDDLE EAST AND AFRICA CLINICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 61 MIDDLE EAST AND AFRICA HOMECARE IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION) 

TABLE 62 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 63 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 64 MIDDLE EAST AND AFRICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 

TABLE 65 MIDDLE EAST AND AFRICA HOSPITAL PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 66 MIDDLE EAST AND AFRICA RETAIL PHARMACY & DRUG STORE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 67 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 68 MIDDLE EAST AND AFRICA OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION) 

TABLE 69 MIDDLE EAST & AFRICA HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 

TABLE 70 MIDDLE EAST & AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 71 MIDDLE EAST & AFRICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 72 MIDDLE EAST & AFRICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 73 MIDDLE EAST & AFRICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION) 

TABLE 74 MIDDLE EAST & AFRICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION) 

TABLE 75 MIDDLE EAST & AFRICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION) 

TABLE 76 MIDDLE EAST & AFRICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION) 

TABLE 77 MIDDLE EAST & AFRICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION) 

TABLE 78 MIDDLE EAST & AFRICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION) 

TABLE 79 MIDDLE EAST & AFRICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 

TABLE 80 MIDDLE EAST & AFRICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION) 

TABLE 81 MIDDLE EAST & AFRICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION) 

TABLE 82 MIDDLE EAST & AFRICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION) 

TABLE 83 MIDDLE EAST & AFRICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION) 

TABLE 84 MIDDLE EAST & AFRICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION) 

TABLE 85 MIDDLE EAST & AFRICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION) 

TABLE 86 MIDDLE EAST & AFRICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION) 

TABLE 87 MIDDLE EAST & AFRICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 

TABLE 88 SOUTH AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 89 SOUTH AFRICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 90 SOUTH AFRICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 

TABLE 91 SOUTH AFRICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION) 

TABLE 92 SOUTH AFRICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION) 

TABLE 93 SOUTH AFRICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION) 

TABLE 94 SOUTH AFRICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION) 

TABLE 95 SOUTH AFRICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION) 

TABLE 96 SOUTH AFRICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION) 

TABLE 97 SOUTH AFRICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 

TABLE 98 SOUTH AFRICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION) 

TABLE 99 SOUTH AFRICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION) 

TABLE 100 SOUTH AFRICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION) 

TABLE 101 SOUTH AFRICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION) 

TABLE 102 SOUTH AFRICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION) 

TABLE 103 SOUTH AFRICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION) 

TABLE 104 SOUTH AFRICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION) 

TABLE 105 SOUTH AFRICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 

TABLE 106 REST OF MIDDLE EAST & AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19